mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.2 |
0.5 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.5 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
0.096 |
0.5 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |